Michael G. Brattain - Concepedia

Author

Michael G. Brattain

Also Known As

Brattain, M. G., Brattain, Michael G., M BRATTAIN, M Brattain, M G Brattain, M. Brattain, M. G. Brattain, M.G. BRATTAIN, M.G. Brattain, MICHAEL G. BRATTAIN

276

Publications

14.4K

Citations

H-Index

104

Concepts

All Affiliations

Baylor College of Medicine Roswell Park Comprehensive Cancer Center The University of Texas Health Science Center at San Antonio University of Nebraska Medical Center University of Toledo Medical Center

About

Michael G. Brattain is an author at Baylor College of Medicine specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	113	7.5K
2	Health Sciences	15	18	814
3	Natural Sciences	12	12	839
4	Education	1	1	38
5	Public Health	1	1	13

Michael G. Brattain

176

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Heterogeneity of malignant cells from a human colonic carcinoma. Michael G. Brattain, W D Fine, Fadl Khaled, PubMed Tumor BiologyOncologyLatency PeriodGastrointestinal OncologyMalignant Disease	1981	483
Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Isabelle Chantret, Alain Barbat, E Dussaulx, PubMed PathologyCell ProliferationCytoskeletonTwenty Cell LinesCancer Biology	1988	449
Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. William M. Grady, Lois L. Myeroff, Sandra E. Swinler, PubMed Tumor BiologyOncologyMedicineMicrosatellite InstabilityColorectal Cancer	1999	392
Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells Jing Wang, Lu‐Zhe Sun, Lois L. Myeroff, Journal of Biological Chemistry	1995	337
Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Shazli N. Malik, Michael G. Brattain, P. Ghosh, PubMed	2002	322
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells Lu‐Zhe Sun, Guanming Wu, James K. V. Willson, Journal of Biological Chemistry Tumor BiologyTgf Beta 1Breast OncologyGrowth FactorTumor Growth	1994	321
The maximal size of protein to diffuse through the nuclear pore is larger than 60 kDa Ruiwen Wang, Michael G. Brattain FEBS Letters	2007	252
Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Michael G. Brattain, Janna D. Strobel‐Stevens, David Fine, PubMed Gastrointestinal OncologyMedicinePathologyColorectal CancerCancer Cell Biology	1980	234
Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Byron H. Long, Steven T. Musial, Michael G. Brattain PubMed Dna Breakage PlateausVm26-induced Dna BreakageGenome InstabilityDna DamageDna Breakage	1985	189
Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship Byron H. Long, Steven T. Musial, Michael G. Brattain Biochemistry	1984	183

Page 1